← SynDRA
DILMAPIMOD
SynDRA canonical compound SYN0030041 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | p38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
Cross-references
Synonyms
- Gw-681323
- SB-681323
- SB681323
- SB 681323
- UNII-Q3238VQW0N
- GW-681323
- Q3238VQW0N
- GW681323
- Dilmapimod [USAN:INN]
- GSK 681323
- Dilmapimod (USAN/INN)
- GTPL7815
- SCHEMBL1065268
- CHEMBL2103838
- ORVNHOYNEHYKJG-UHFFFAOYSA-N
- BCP23819
- ZINC34997404
- CS-6731
- DB12140
- SB16737
- 8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-Pyrido[2,3-d]pyrimidin-7(8H)-one
- HY-10404
- DB-070558
- FT-0718750
- J3.498.915J
- D09602
- dilmapimodum
- RefChem:587981
- DTXCID401748150
- SB-681323; GW-681323
- Dilmapimod [USAN]
- MFCD16659063
- DILMAPIMOD [INN]
- orb1309122
- Dilmapimod (SB-681323)?
- SCHEMBL29372394
- SCHEMBL29379709
- SCHEMBL29528002
- GLXC-21272
Look up DILMAPIMOD in the interactive SynDRA portal →